Premium
Simultaneous determination of methylephedrine and pseudoephedrine in human urine by CE with electrochemiluminescence detection and its application to pharmacokeinetics
Author(s) -
Liu YanMing,
Tian Wei,
Jia YuXiu,
Yue HaiYan
Publication year - 2009
Publication title -
biomedical chromatography
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.4
H-Index - 65
eISSN - 1099-0801
pISSN - 0269-3879
DOI - 10.1002/bmc.1235
Subject(s) - pseudoephedrine , chemistry , chromatography , detection limit , urine , capillary electrophoresis , electrochemiluminescence , ephedrine , biochemistry , neuroscience , biology
A novel method for the determination of ephedra alkaloids (methylephedrine and pseudoephedrine) was developed by electrophoresis capillary (CE) separation and electrochemiluminesence detection (ECL). The use of ionic liquid (1‐butyl‐3‐methylimidazolium tetrafluoroborate, BMIMBF 4 ) improved the detection sensitivity markedly. The conditions for CE separation, ECL detection and effect of ionic liquid were investigated in detail. The two ephedra alkaloids with very similar structures were well separated and detected under the optimum conditions. The limits of detection (signal‐to‐noise ratio = 3) in standard solution were 1.8 × 10 –8 mol/L for methylephedrine (ME) and 9.2 × 10 –9 mol/L for pseudoephedrine (PSE). The limits of quantitation (signal‐to‐noise ratio = 10) in human urine samples were 2.6 × 10 −7 mol/L for ME and 3.6 × 10 –7 mol/L for PSE. The recoveries of two alkaloids at three different concentration levels in human urine samples were between 81.7 and 105.0%. The proposed method was successfully applied to the determination of ME and PSE in human urine and the monitoring of pharmacokinetics for PSE. The proposed method has potential in therapeutic drug monitoring and clinical analysis. Copyright © 2009 John Wiley & Sons, Ltd.